|
1
|
Go H, Hwang HJ and Nam TJ: Polysaccharides
from Capsosiphon fulvescens stimulate the growth of IEC-6
cells by activating the MAPK signaling pathway. Mar Biotechnol.
13:433–440. 2011.
|
|
2
|
Yoshizawa Y, Ametani A, Tsunehiro, Nomura
K, Itoh M, Fukui F and Kaminogawa S: Macrophage stimulation
activity of the polysaccharide fraction from a marine alga
(Porphyra yezoensis): structure-function relationships and
improved solubility. Biosci Biotechnol Biochem. 59:1933–1937. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He L, Huang A, Shen S, Niu J and Wang G:
Comparative analysis of microRNAs between sporophyte and
gametophyte of Porphyra yezoensis. Comp Funct Genomics.
912843:2012
|
|
4
|
Shen S, Zhang G, Li Y, Wang L, Xu P and Yi
L: Comparison of RNA expression profiles on generation of
Porphyra yezoensis(Rhodophyta), based on suppression
subtractive hybridization (SSH). BMC Res Notes.
4:4282011.PubMed/NCBI
|
|
5
|
Butler AA, Blakesley VA, Poulaki V, Tsokos
M, Wood TL and LeRoith D: Stimulation of tumor growth by
recombinant human insulin-like growth factor-I (IGF-I) is dependent
on the dose and the level of IGF-I receptor expression. Cancer Res.
58:3021–3027. 1998.
|
|
6
|
Rubini M, Hongo A, D’Ambrosio C and
Baserga R: The IGF-I receptor in mitogenesis and transformation of
mouse embryo cells: role of receptor number. Exp Cell Res.
230:284–292. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reiss K, Valentinis B, Tu X, Xu SQ and
Baserga R: Molecular markers of IGF-I-mediated mitogenesis. Exp
Cell Res. 242:361–372. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Butler AA, Yakar S, Gewolb IH, Karas M,
Okubo Y and LeRoith D: Insulin-like growth factor-I receptor signal
transduction: at the interface between physiology and cell biology.
Comp Biochem Physiol B Biochem Mol Biol. 121:19–26. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Go H, Hwang HJ and Nam TJ: A glycoprotein
from Laminaria japonica induces apoptosis in HT-29 colon
cancer cells. Toxicol In Vitro. 24:1546–1553. 1998.
|
|
10
|
Khan N, Adhami VM and Mukhtar H: Apoptosis
by dietary agents for prevention and treatment of cancer. Biochem
Pharmacol. 76:1333–1339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burz C, Berindan-Neagoe I, Balacescu O and
Irimie A: Apoptosis in cancer: key molecular signaling pathways and
therapy targets. Acta Oncol. 48:811–821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson DG and Walker CL: Cyclins and cell
cycle checkpoints. Annu Rev Pharmacol Toxicol. 39:295–312. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weinstein IB: Disorders in cell circuitry
during multistage carcinogenesis: the role of homeostasis.
Carcinogenesis. 21:857–864. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan-Hui PY and Weaver R: Human
mitogen-activated protein kinase kinase kinase mediates the
stress-induced activation of mitogen-activated protein kinase
cascades. Biochem J. 336:599–609. 1998.PubMed/NCBI
|
|
15
|
Wang HJ, Tashiro S, Onodera S and Ikejima
T: Inhibition of insulin-like growth factor 1 receptor signaling
enhanced silibinin-induced activation of death receptor and
mitochondrial apoptotic pathways in human breast cancer MCF-7
cells. J Pharmacol Sci. 107:260–269. 2008. View Article : Google Scholar
|
|
16
|
Naumann U, Weit S, Rieger L, Meyermann R
and Weller M: p27 modulates cell cycle progression and
chemosensitivity in human malignant glioma. Biochem Biophys Res
Commun. 261:890–896. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vangestel C, Peeters M, Oltenfreiter R,
D’Asseler Y, Staelens S, Van Steenkiste M, Philippé J, Kusters D,
Reutelingsperger C, Van Damme N and Van de Wiele C: In vitro and in
vivo evaluation of [99mTc]-labeled tricarbonyl His-Annexin A5 as an
imaging agent for the detection of phosphatidylserine-expressing
cells. Nucl Med Biol. 37:965–975. 2010.
|
|
18
|
Khandwala HM, McCutcheon IE, Flyvbjerg A
and Friend KE: The effects of insulin-like growth factors on
tumorigenesis and neoplastic growth. End Rev. 21:215–244. 2000.
View Article : Google Scholar
|
|
19
|
White MF and Kahn CR: The insulin
signaling system. J Biol Chem. 269:1–4. 1994.
|
|
20
|
Dews M, Prisco M, Peruzzi F, Romano G,
Morrione A and Baserga R: Domains of the insulin-like growth factor
I receptor required for the activation of extracellular
signal-regulated kinase. Endocrinology. 141:1289–1300.
2000.PubMed/NCBI
|
|
21
|
White MF: The IRS-signaling system: a
network of docking proteins that mediate insulin and cytokine
action. Recent Prog Horm Res. 53:119–138. 1998.
|
|
22
|
Scaltriti M and Baselga J: The epidermal
growth factor receptor pathway: a model for targeted therapy. Clin
Cancer Res. 12:5268–5272. 2006. View Article : Google Scholar
|
|
23
|
Kandel ES and Hay N: The regulation and
activities of the multifunctional serine/threonine kinase Akt/PKB.
Exp Cell Res. 253:210–229. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parrizas M, Saltiel AR and LeRoith D:
Insulin-like growth factor I inhibits apoptosis using
phosphatidylinositol 3′-kinase and mitogen-activated protein kinase
pathways. J Biol Chem. 272:154–161. 1997.
|
|
25
|
McCurdy CE and Cartee GD: Akt2 is
essential for the full effect of calorie restriction on
insulin-stimulated glucose uptake in skeletal muscle. Diabetes.
54:1349–1356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang HJ, Kwon MJ and Nam TJ:
Chemoprotective effect of insulin-like growth factor I against
acetaminophen-induced cell death in Chang liver cells via ERK1/2
activation. Toxicology. 230:76–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S,
Minami M and Ikejima T: P53-mediated cell cycle arrest and
apoptosis through a caspase-3-independent, but caspase-9-dependent
pathway in oridonin-treated MCF-7 human breast cancer cells. Acta
Pharmacol Sin. 28:1057–1066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Quinn KA, Treston AM, Unsworth EJ, Miller
MJ, Vos M, Grimley C, Battey J, Mulshine JL and Cuttitta F:
Insulin-like growth factor expression in human cancer cell lines. J
Biol Chem. 271:11477–11483. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ibrahim YH and Yee D: Insulin-like growth
factor-I and breast cancer therapy. Clin Cancer Res. 11:944s–950s.
2005.PubMed/NCBI
|
|
30
|
Shen G, Xu C, Chen C, Hebbar V and Kong
AN: P53-independent G1 cell cycle arrest of human colon carcinoma
cells HT-29 by sulforaphane is associated with induction of
p21cip1and inhibition of expression of cyclin D1. Cancer
Chemother Pharmacol. 57:317–327. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu ZY, Sun J, Zhu XF, Yang D and Zeng YX:
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells
by suppressing the c-Myc signaling pathway. J Transl Med. 7:742009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pucci B, Kasten M and Giodano A: Cell
cycle and apoptosis. Neoplasia. 2:291–299. 2000. View Article : Google Scholar
|
